Nurse’s death linked to weight-loss drug Mounjaro approved on NHS

Susan McGowan, a nurse from North Lanarkshire, died two weeks after taking tirzepatide, a weight-loss drug marketed as Mounjaro. Her death has been linked to the drug, with multiple organ failure, septic shock, and pancreatitis listed as causes. McGowan had taken two injections of the drug before experiencing severe side effects. The drug was approved in the UK in 2023, but reports of serious reactions and even suspected deaths have been logged. The manufacturer, Lilly, maintains that patient safety is a top priority. Other GLP-1 receptor agonists like semaglutide have also been linked to suspected deaths in the UK. Experts caution that while weight-loss drugs have benefits, their safety must be carefully monitored.

Full Article